Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

The Role of Caveolin 1 in HIV Infection and Pathogenesis.

Mergia A.

Viruses. 2017 May 26;9(6). pii: E129. doi: 10.3390/v9060129. Review.

2.

Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents.

Margolis DM, Archin NM.

J Infect Dis. 2017 Mar 15;215(suppl_3):S111-S118. doi: 10.1093/infdis/jiw618. Review.

PMID:
28520964
4.

Are T cells the only HIV-1 reservoir?

Kandathil AJ, Sugawara S, Balagopal A.

Retrovirology. 2016 Dec 20;13(1):86. doi: 10.1186/s12977-016-0323-4. Review. Erratum in: Retrovirology. 2017 Feb 8;14 (1):11.

5.

Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID in a Viral Outgrowth Assay.

Lee SK, Zhou S, Baldoni PL, Spielvogel E, Archin NM, Hudgens MG, Margolis DM, Swanstrom R.

J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):221-228. doi: 10.1097/QAI.0000000000001187.

PMID:
27683060
6.

Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study.

Lake JE, Seang S, Kelesidis T, Currier JS, Yang OO.

HIV Clin Trials. 2016 Nov;17(6):225-232. Epub 2016 Sep 23.

PMID:
27658740
7.

Tetherin Antagonism by HIV-1 Group M Nef Proteins.

Arias JF, Colomer-Lluch M, von Bredow B, Greene JM, MacDonald J, O'Connor DH, Serra-Moreno R, Evans DT.

J Virol. 2016 Sep 21. pii: JVI.01465-16. [Epub ahead of print]

8.

Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers.

Policicchio BB, Xu C, Brocca-Cofano E, Raehtz KD, He T, Ma D, Li H, Sivanandham R, Haret-Richter GS, Dunsmore T, Trichel A, Mellors JW, Hahn BH, Shaw GM, Ribeiro RM, Pandrea I, Apetrei C.

PLoS Pathog. 2016 Sep 15;12(9):e1005879. doi: 10.1371/journal.ppat.1005879. eCollection 2016 Sep.

9.

Tissue reservoirs of HIV.

Wong JK, Yukl SA.

Curr Opin HIV AIDS. 2016 Jul;11(4):362-70. doi: 10.1097/COH.0000000000000293.

10.

Animal models to achieve an HIV cure.

Kumar N, Chahroudi A, Silvestri G.

Curr Opin HIV AIDS. 2016 Jul;11(4):432-41. doi: 10.1097/COH.0000000000000290.

11.

P2X7 Receptor Inhibition Improves CD34 T-Cell Differentiation in HIV-Infected Immunological Nonresponders on c-ART.

Menkova-Garnier I, Hocini H, Foucat E, Tisserand P, Bourdery L, Delaugerre C, Benne C, Lévy Y, Lelièvre JD.

PLoS Pathog. 2016 Apr 15;12(4):e1005571. doi: 10.1371/journal.ppat.1005571. eCollection 2016 Apr.

12.

HIV-1 Latency and Eradication: Past, Present and Future.

Datta PK, Kaminski R, Hu W, Pirrone V, Sullivan NT, Nonnemacher MR, Dampier W, Wigdahl B, Khalili K.

Curr HIV Res. 2016;14(5):431-441.

13.

HIV-1 Reservoirs During Suppressive Therapy.

Barton K, Winckelmann A, Palmer S.

Trends Microbiol. 2016 May;24(5):345-55. doi: 10.1016/j.tim.2016.01.006. Epub 2016 Feb 12. Review.

14.

HIV-1 functional cure: will the dream come true?

Liu C, Ma X, Liu B, Chen C, Zhang H.

BMC Med. 2015 Nov 20;13:284. doi: 10.1186/s12916-015-0517-y. Review.

15.

Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1.

Martínez-Bonet M, Clemente MI, Serramía MJ, Muñoz E, Moreno S, Muñoz-Fernández MÁ.

Sci Rep. 2015 Nov 13;5:16445. doi: 10.1038/srep16445.

16.

A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral Therapy.

DeMaster LK, Liu X, VanBelzen DJ, Trinité B, Zheng L, Agosto LM, Migueles SA, Connors M, Sambucetti L, Levy DN, Pasternak AO, O'Doherty U.

J Virol. 2015 Nov 4;90(5):2165-79. doi: 10.1128/JVI.01913-15.

17.

Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4+ T Lymphocytes.

Collins DR, Lubow J, Lukic Z, Mashiba M, Collins KL.

PLoS Pathog. 2015 Jul 17;11(7):e1005054. doi: 10.1371/journal.ppat.1005054. eCollection 2015 Jul.

18.

Therapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells.

Iordanskiy S, Van Duyne R, Sampey GC, Woodson CM, Fry K, Saifuddin M, Guo J, Wu Y, Romerio F, Kashanchi F.

Virology. 2015 Nov;485:1-15. doi: 10.1016/j.virol.2015.06.021. Epub 2015 Jul 14.

19.

Reactivation of latent HIV-1 provirus via targeting protein phosphatase-1.

Tyagi M, Iordanskiy S, Ammosova T, Kumari N, Smith K, Breuer D, Ilatovskiy AV, Kont YS, Ivanov A, Üren A, Kovalskyy D, Petukhov M, Kashanchi F, Nekhai S.

Retrovirology. 2015 Jul 16;12:63. doi: 10.1186/s12977-015-0190-4.

20.

HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape.

Carroll V, Garzino-Demo A.

Pathog Dis. 2015 Oct;73(7). pii: ftv044. doi: 10.1093/femspd/ftv044. Epub 2015 Jun 29. Review.

Supplemental Content

Support Center